AI-Integrated Phenobarbital Sodium Stabilization System

Publication ID: 24-11857683_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “AI-Integrated Phenobarbital Sodium Stabilization System,” Published Technical Disclosure No. 24-11857683_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857683_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,683.

Summary of the Inventive Concept

A novel system integrating AI, IoT, blockchain, and advanced materials to enhance the stability and quality of phenobarbital sodium for injection, ensuring real-time monitoring and optimization throughout the supply chain and administration process.

Background and Problem Solved

The original patent disclosed a lyophilized pharmaceutical composition of phenobarbital or salts thereof with improved stability. However, the patent did not address the need for real-time monitoring, optimization, and verification of the composition throughout the supply chain and administration process. The new inventive concept solves this problem by integrating distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The AI-Integrated Phenobarbital Sodium Stabilization System consists of a lyophilized pharmaceutical composition with an ethanol content in the range from 12000 ppm to 50000 ppm, an AI-powered monitoring module for tracking ethanol content and total impurities in real-time, IoT-enabled sensors for detecting and adjusting the vehicle/diluent composition for injection, a blockchain-based platform for tracking and verifying the authenticity and quality of the composition throughout the supply chain, and a novel material composition incorporating graphene oxide and silver nanoparticles to enhance stability and reduce total impurities. The system also includes a smart injection device integrated with a machine learning algorithm, capable of automatically adjusting the dose and composition of phenobarbital sodium for injection based on patient-specific data and real-time monitoring.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and advanced materials, which is not obvious from the original patent. The inventive step lies in the synergistic combination of these technologies to create a more powerful system for stabilizing phenobarbital sodium for injection.

Alternative Embodiments and Variations

Alternative embodiments could include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations could also involve the integration of additional technologies, such as robotics or virtual reality, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The AI-Integrated Phenobarbital Sodium Stabilization System has significant commercial potential in the pharmaceutical industry, particularly in the areas of neonatal seizure treatment and critical care. The system's real-time monitoring and optimization capabilities could also be applied to other pharmaceutical compositions, expanding its market potential.

CPC Classifications

Section	Class	Group
A	A61	A61K9/19
A	A61	A61K9/08
A	A61	A61K31/515
A	A61	A61K47/10
A	A61	A61P25/08

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Pharmaceutical formulation and drug delivery systems, specifically focusing on lyophilized injectable pharmaceutical compositions, with expertise in stability optimization, analytical chemistry, and pharmaceutical engineering

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree (PhD or equivalent) in pharmaceutical sciences, with expertise in drug formulation, stability testing, analytical techniques, and emerging technologies in pharmaceutical manufacturing and delivery

Obviousness Rationale

A PHOSITA would recognize that the PTD's integration of AI, IoT, and advanced materials represents a predictable application of known technologies to solve existing challenges in pharmaceutical stability and delivery. The core pharmaceutical composition remains substantially identical to the source patent, with the added technological monitoring and optimization layers representing incremental improvements using standard engineering approaches. The technical solutions proposed are logical extensions of existing pharmaceutical engineering practices, particularly in quality control and supply chain management.

Obvious Combinations & Variations

Source Patent Element

Lyophilized phenobarbital sodium composition with specific ethanol content range

PTD Variation

AI-powered monitoring module tracking ethanol content and impurities in real-time

Obviousness Reasoning

Real-time analytical monitoring is a known technique in pharmaceutical quality control, representing a predictable application of existing sensor and machine learning technologies to enhance existing formulation tracking

Source Patent Element

Pharmaceutical composition with controlled impurity levels

PTD Variation

Incorporation of graphene oxide and silver nanoparticles to enhance stability and reduce total impurities

Obviousness Reasoning

Material science approaches to enhancing pharmaceutical stability are well-established, and the use of nanomaterials for improving drug formulation represents a known strategy in pharmaceutical engineering

Source Patent Element

Method for treating neonatal seizures with phenobarbital sodium

PTD Variation

Smart injection device with machine learning algorithm for patient-specific dose adjustment

Obviousness Reasoning

Personalized medicine and adaptive dosing technologies are emerging standard approaches in pharmaceutical delivery, representing a logical extension of existing clinical management strategies

Source Patent Element

Lyophilized pharmaceutical composition with defined storage parameters

PTD Variation

Blockchain-based platform for tracking composition authenticity and quality throughout supply chain

Obviousness Reasoning

Supply chain authentication and tracking technologies are standard approaches in pharmaceutical manufacturing, representing a predictable application of existing blockchain and IoT technologies

Source Patent Element

Pharmaceutical composition with controlled ethanol content

PTD Variation

IoT-enabled sensors for detecting and adjusting vehicle/diluent composition

Obviousness Reasoning

Dynamic composition adjustment using sensor technologies is a known technique in pharmaceutical formulation, representing a predictable application of existing sensor and control system technologies

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857683 and the present published technical disclosure, a person having ordinary skill in the art would find the proposed technological variations obvious and predictable extensions of existing pharmaceutical engineering practices, thereby rendering potential claims to such technologies unpatentable under 35 U.S.C. § 103 due to the combination of prior art teachings and standard engineering approaches.

Original Patent Information

Patent Number	US 11,857,683
Title	Stabilization of phenobarbital sodium for injection
Assignee(s)	SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED